This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Crescendo Biologics Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Phil Hayes: Innovator in Antibody Technology
Introduction
Phil Hayes is a distinguished inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic agents.
Latest Patents
Phil Hayes holds a patent for "Single domain antibodies to programmed cell death protein 1 (PD-1)." This invention relates to PD-1 binding agents that block the interaction of PD-1 with its ligands. The use of such binding agents is crucial in the treatment, prevention, and detection of various diseases.
Career Highlights
Phil is currently associated with Crescendo Biologics Limited, where he continues to advance his research and development efforts. His work focuses on creating novel therapeutic solutions that can significantly impact patient care.
Collaborations
Phil collaborates with talented professionals in his field, including James Legg and Martyna Lewandowska. Their combined expertise fosters an environment of innovation and progress in antibody technology.
Conclusion
Phil Hayes exemplifies the spirit of innovation in biotechnology through his groundbreaking work on PD-1 binding agents. His contributions are paving the way for new therapeutic approaches in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile